Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Welte

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
Haematologica|November 8, 2011
Low platelet counts after induction therapy for childhood acute lymphoblastic leukemia are strongly associated with poor early response to treatment as measured by minimal residual disease and are prognostic for treatment outcomeLutz Zeidler, Martin Zimmermann, Anja Möricke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantationBritta Maecker, Thomas Jack, Martin Zimmermann, et al.
Haematologica|March 27, 2025
Genetic and clinical characteristics of patients with Shwachman Diamond syndrome with special consideration of treatment with granulocyte-colony stimulating factorSabine Mellor-Heineke, Julia Skokowa, Natali Gerschmann, et al.
Haematologica|June 29, 2019
CRISPR/Cas9-mediated <i>ELANE</i> knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patientsMasoud Nasri, Malte Ritter, Perihan Mir, et al.
Hemasphere|April 17, 2025
European guidelines on treatment and supportive measures in chronic neutropenias: A consensus between the European Hematology Association and the EuNet-INNOCHRON COST Action based on a systematic evidence reviewFrancesca Fioredda, Michail Spanoudakis, Julia Skokowa, et al.
Cell Research|April 9, 2014
Double-stranded DNA in exosomes: a novel biomarker in cancer detectionBasant Kumar Thakur, Haiying Zhang, Annette Becker, et al.
Cell Stem Cell|April 24, 2021
iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropeniaBenjamin Dannenmann, Maksim Klimiankou, Benedikt Oswald, et al.
Cell Stem Cell|September 8, 2023
iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropeniaBenjamin Dannenmann, Maksim Klimiankou, Benedikt Oswald, et al.
Translational Lung Cancer Research|August 9, 2024
Real-world biomarker testing patterns: clinical-pathological portrait of early and late non-small cell lung cancer in hub and spoke North Italian centersMariaenrica Tinè, Federica Pezzuto, Manuela Orlandi, et al.
Blood|August 2, 2019
LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesisTatsuya Morishima, Ann-Christin Krahl, Masoud Nasri, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Haematologica|November 8, 2011
Low platelet counts after induction therapy for childhood acute lymphoblastic leukemia are strongly associated with poor early response to treatment as measured by minimal residual disease and are prognostic for treatment outcomeLutz Zeidler, Martin Zimmermann, Anja Möricke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantationBritta Maecker, Thomas Jack, Martin Zimmermann, et al.
Haematologica|March 27, 2025
Genetic and clinical characteristics of patients with Shwachman Diamond syndrome with special consideration of treatment with granulocyte-colony stimulating factorSabine Mellor-Heineke, Julia Skokowa, Natali Gerschmann, et al.
Haematologica|June 29, 2019
CRISPR/Cas9-mediated <i>ELANE</i> knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patientsMasoud Nasri, Malte Ritter, Perihan Mir, et al.
Hemasphere|April 17, 2025
European guidelines on treatment and supportive measures in chronic neutropenias: A consensus between the European Hematology Association and the EuNet-INNOCHRON COST Action based on a systematic evidence reviewFrancesca Fioredda, Michail Spanoudakis, Julia Skokowa, et al.
Cell Research|April 9, 2014
Double-stranded DNA in exosomes: a novel biomarker in cancer detectionBasant Kumar Thakur, Haiying Zhang, Annette Becker, et al.
Cell Stem Cell|April 24, 2021
iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropeniaBenjamin Dannenmann, Maksim Klimiankou, Benedikt Oswald, et al.
Cell Stem Cell|September 8, 2023
iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropeniaBenjamin Dannenmann, Maksim Klimiankou, Benedikt Oswald, et al.
Translational Lung Cancer Research|August 9, 2024
Real-world biomarker testing patterns: clinical-pathological portrait of early and late non-small cell lung cancer in hub and spoke North Italian centersMariaenrica Tinè, Federica Pezzuto, Manuela Orlandi, et al.
Blood|August 2, 2019
LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesisTatsuya Morishima, Ann-Christin Krahl, Masoud Nasri, et al.
Pageof 15